Marc-Yves Bächli

Gorba AG supplies complete passenger information systems for public transportation. It provides exterior displays, interior displays, control units, on board computers, countdown displays, matrix and Thin Film Transistor displays, as well as central software for destination and stationary systems, and software for operations management. The firm also offers accessories like passenger counters and exterior cameras. The company was founded on 1982 and is headquartered in Oberbüren, Switzerland.

PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland.

Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland.

Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022.

Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company is based in Basel, Switzerland and was founded in 2014.

Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier.

Clarena AG provides business management consultancy services. The private company is based in Basel, Switzerland. The Swiss company was founded by Roger Meier.

Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland.

Nemis Technologies AG provides food safety solutions through their n-light environmental monitoring series. The company is based in Dübendorf, Switzerland and was founded in 2018 by Roger Meier, Arnaud Muller, Mario Hupfeld, and Urs Breitenstein. The Swiss company's E.coli rapid test is a part of this series and enables pathogen detection in food processing. Arnaud Muller has been the CEO since 2018.